Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Oncology Innovations

Episode 1: The Value and Opportunity in Individualized Cancer Care: Part 1


Read the Transcript

In this 2-part series, Gordon Kuntz, Kuntz Consulting, interviews Bryan Loy, MD, MBA, Physician Lead for Oncology, Laboratory, and Personalized Medicine at Humana, and Tushar Pandey, MBA, CEO of SimBioSys, about the value and opportunity in individualized cancer care.

In the first installment, Gordon, Dr Loy, and Tushar discuss current approaches to personalized medicine, how precision medicine has evolved in recent years, challenges that remain, and considerations for the future.

Watch part 2, where Gordon, Dr Loy, and Tushar discuss the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.

Advertisement

Advertisement

Advertisement